Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
Alcohol Clin Exp Res. 2018 Jan;42(1):21-31. doi: 10.1111/acer.13526. Epub 2017 Nov 27.
Alcohol's reinforcement is mediated by dopamine signaling in the ventral striatum, which is modulated by the dopamine transporter (DAT). We hypothesized that methylomic variation in the DAT gene (DAT1/SLC6A3) affects DAT expression, thus contributing to differences in brain reward circuitry in individuals with alcohol dependence (ALC).
Blood from 45 recently detoxified ALC and 45 healthy control (HC) individuals was used to assess DNA methylation across 5 functional regions of SLC6A3. Participants completed the monetary incentive delay task in a 3-Tesla magnetic resonance imaging (MRI) scanner. Employing regression models, we examined effects of SLC6A3 methylation on nucleus accumbens (NAc) blood-oxygen-level dependent (BOLD) responses during anticipation of high/low reward/loss.
Results showed that decreased methylation of the promoter region of SLC6A3 predicted NAc activation during high loss anticipation (p = 0.028) and low loss anticipation (at trend-level; p = 0.057) in HC but not in individuals with ALC. Specifically, percentage of methylation at 2 CpG sites, located -1,001 and -993 base pairs from the transcription start site, accounted for significant variability in NAc activation in the HC group during high (ps ≤ 0.010) and low (ps ≤ 0.006) loss anticipation. There was no effect on reward anticipation. Furthermore, promoter methylation was positively associated with age, which replicates previous findings.
Our data suggest that methylation in the promoter region of SLC6A3 predicts NAc activation during the anticipation of monetary loss in HCs. However, this effect was not present in the ALC group, suggesting that epigenetic regulation of striatal DAT expression might be disrupted in ALC, which may contribute to previously reported differences in sensitivity to reward and punishment in this population. Alternatively, it is possible that a similar relationship in the ALC group remained undetected possibly due to methodological limitations inherent in functional MRI (e.g., poor spatial resolution, low signal-to-noise ratio) that generally restrict interpretations regarding mechanisms of epigenetic factors involved in group differences in BOLD responses. Future neuroimaging studies are needed to further elucidate the relationship between SLC6A3 methylation and NAc activation in ALC.
酒精的强化作用是通过腹侧纹状体中的多巴胺信号介导的,多巴胺转运蛋白(DAT)对其进行调节。我们假设多巴胺转运体基因(DAT1/SLC6A3)中的甲基组变异会影响 DAT 的表达,从而导致酒精依赖个体(ALC)大脑奖励回路存在差异。
使用来自 45 名新近戒酒的 ALC 和 45 名健康对照(HC)个体的血液,评估 SLC6A3 的 5 个功能区域的 DNA 甲基化。参与者在 3T 磁共振成像(MRI)扫描仪中完成货币奖励延迟任务。采用回归模型,我们研究了 SLC6A3 甲基化对预期高/低奖赏/损失时伏隔核(NAc)血氧水平依赖(BOLD)反应的影响。
结果显示,SLC6A3 启动子区域的甲基化减少预示着 HC 个体在高损失预期(p=0.028)和低损失预期(在趋势水平;p=0.057)期间 NAc 的激活,而在 ALC 个体中则没有。具体来说,位于转录起始位点前 -1001 和 -993 个碱基对的 2 个 CpG 位点的甲基化百分比,解释了 HC 组在高(p≤0.010)和低(p≤0.006)损失预期期间 NAc 激活的显著变异性。对奖赏预期没有影响。此外,启动子甲基化与年龄呈正相关,这与之前的发现一致。
我们的数据表明,SLC6A3 启动子区域的甲基化可预测 HC 个体在预期货币损失时 NAc 的激活。然而,在 ALC 组中并未出现这种情况,这表明 ALC 中纹状体 DAT 表达的表观遗传调控可能受到破坏,这可能导致该人群对奖赏和惩罚的敏感性存在先前报道的差异。或者,ALC 组中可能存在类似的关系,但由于功能磁共振成像(fMRI)固有的方法学限制(例如,空间分辨率差、信噪比低)而无法检测到,这通常限制了对涉及 BOLD 反应中组间差异的表观遗传因素机制的解释。需要进一步的神经影像学研究来阐明 ALC 中 SLC6A3 甲基化与 NAc 激活之间的关系。